Federated Hermes
CCXI

Federated Hermes’s ChemoCentryx, Inc. CCXI Stock Holding History

Federated Hermes’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-49,161
Closed -$1.23M – 2342
2022
Q1 		$1.23M Buy
+49,161
New +$1.38M ﹤0.01% 1182
2021
Q4 		– Sell
-543,502
Closed -$9.29M – 2357
2021
Q3 		$9.29M Buy
+543,502
New +$8.47M 0.02% 664
2021
Q1 		– Sell
-34,073
Closed -$2.11M – 2399
2020
Q4 		$2.11M Sell
34,073
-12,188
-26% -$698K ﹤0.01% 1045
2020
Q3 		$2.54M Sell
46,261
-22,413
-33% -$1.21M 0.01% 905
2020
Q2 		$3.95M Buy
68,674
+30,726
+81% +$1.67M 0.01% 773
2020
Q1 		$1.52M Buy
37,948
+21,312
+128% +$905K ﹤0.01% 978
2019
Q4 		$658K Sell
16,636
-7,782
-32% -$137K ﹤0.01% 1386
2019
Q3 		$165K Sell
24,418
-126,408
-84% -$949K ﹤0.01% 1606
2019
Q2 		$1.4M Buy
150,826
+150,286
+27,831% +$1.74M ﹤0.01% 1184
2019
Q1 		$8K Sell
540
-65,221
-99% -$746K ﹤0.01% 1911
2018
Q4 		$717K Hold
65,761
– – ﹤0.01% 1368
2018
Q3 		$831K Sell
65,761
-808
-1% -$9.73K ﹤0.01% 1393
2018
Q2 		$877K Buy
66,569
+12,759
+24% +$153K ﹤0.01% 1325
2018
Q1 		$732K Sell
53,810
-10,800
-17% -$111K ﹤0.01% 1310
2017
Q4 		$384K Hold
64,610
– – ﹤0.01% 1423
2017
Q3 		$479K Sell
64,610
-46,620
-42% -$388K ﹤0.01% 1379
2017
Q2 		$1.04M Buy
111,230
+6,399
+6% +$47K ﹤0.01% 1180
2017
Q1 		$763K Buy
104,831
+12,735
+14% +$91.7K ﹤0.01% 1249
2016
Q4 		$682K Buy
92,096
+90,694
+6,469% +$653K ﹤0.01% 1235
2016
Q3 		$8K Buy
1,402
+183
+15% +$865 ﹤0.01% 1866
2016
Q2 		$5K Buy
+1,219
New +$4.57K ﹤0.01% 1905
2015
Q3 		– Sell
-1,789
Closed -$15K – 2078
2015
Q2 		$15K Buy
1,789
+1,049
+142% +$8.33K ﹤0.01% 1700
2015
Q1 		$6K Buy
+740
New +$5.78K ﹤0.01% 1852

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Federated Hermes's CCXI Position: Q2 2022 in Review

Federated Hermes sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 49,161 shares — an estimated $1.23M sold.

Federated Hermes first reported a position in CCXI in Q1 2015 and held it in 23 quarters. The position peaked at $9.29M in Q3 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

  • Federated Hermes reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
  • Federated Hermes sold 49,161 ChemoCentryx, Inc. shares in Q2 2022, an estimated $1.23M.
  • Federated Hermes first reported a position in ChemoCentryx, Inc. in Q1 2015 and held it in 23 quarters.
  • Federated Hermes's ChemoCentryx, Inc. position peaked at $9.29M in Q3 2021.
  • 182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.